fda warning letters compounded semaglutide telehealth 2025 issued 25 to companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Hims & Hers Health, Inc.

The GIP/GLP-1 dual mechanism delivered substantially better results than semaglutides GLP-1 mono-agonism, establishing that multi-receptor activation provides additive benefits

Unlike motility-based SIBO, which we discussed first, structural SIBO often requires longer-term management

They have a huge market share at this time, and approximately 6% of our patients within a NET clinic are taking these agents, just as 6% of the adult population in the United States is taking these agents

The difference comes down to bioavailability, meaning how much of a dose actually reaches your cells

Combination therapy for MASH, cardiovascular disease, and other comorbidities represents another high-volume publication area

Novo Nordisk initially developed semaglutide in 2012 and markets it under the brand names Ozempic and Rybelsus for diabetes, and under the brand name of Wegovy for weight loss